Racheal Louise Johnson

8PUBLICATIONS
8CO-AUTHORS
Molecular targetsPredictive and prognostic markersPlanning and decision makingCancer therapy (excl. chemotherapy and radiation therapy)Disease surveillance
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 28, 2023
Immune Checkpoint Inhibitors Targeting the PD-1/PD-L1 Pathway in Advanced, Recurrent Endometrial Cancer: A Scoping Review with SWOT Analysis.

Racheal Louise Johnson, Subhasheenee Ganesan, Amudha Thangavelu

|Feb 11, 2023
Development of a Novel Intra-Operative Score to Record Diseases' Anatomic Fingerprints (ANAFI Score) for the Prediction of Complete Cytoreduction in Advanced-Stage Ovarian Cancer by Using Machine Learning and Explainable Artificial Intelligence.

Alexandros Laios, Evangelos Kalampokis, Racheal Johnson

|Dec 22, 2022
Stratification of Length of Stay Prediction following Surgical Cytoreduction in Advanced High-Grade Serous Ovarian Cancer Patients Using Artificial Intelligence; the Leeds L-AI-OS Score.

Alexandros Laios, Daniel Lucas Dantas De Freitas, Gwendolyn Saalmink

|Jul 27, 2022
Factors Predicting Surgical Effort Using Explainable Artificial Intelligence in Advanced Stage Epithelial Ovarian Cancer.

Alexandros Laios, Evangelos Kalampokis, Racheal Johnson

|Apr 23, 2022
Explainable Artificial Intelligence for Prediction of Complete Surgical Cytoreduction in Advanced-Stage Epithelial Ovarian Cancer.

Alexandros Laios, Evangelos Kalampokis, Racheal Johnson

|Dec 24, 2021
The Uncertain Benefit of Adjuvant Chemotherapy in Advanced Low-Grade Serous Ovarian Cancer and the Pivotal Role of Surgical Cytoreduction.

Racheal Louise Johnson, Alexandros Laios, David Jackson

Pageof 2

Frequent Collaborators

7 joint publications

Diederick De Jong

6 joint publications

Alexandros Laios

3 joint publications

Evangelos Kalampokis

3 joint publications

Richard Hutson